By Michael Gwarisa China has launched an aggressive response to a Chikungunya virus outbreak that has infected over 7,000 people, mainly in Foshan, Guangdong Province. The mosquito-borne virus, which causes fever and severe joint pain, has led to hospitalizations lasting up to a week. In a COVID-style response, authorities have deployed drones to locate mosquito
Read MoreBy Michael Gwarisa The World Health Organization (WHO) has issued updated guidelines strongly advising against the use of antibiotics to treat COVID-19 or influenza, emphasizing that these medications are ineffective against viral infections and contribute to the growing threat of antimicrobial resistance (AMR). The guidelines, outlined in a recent WHO evidence brief, stress that antibiotics
Read MoreBy Health Times Correspondent The International AIDS Society (IAS) has applauded a bipartisan effort in the U.S. Senate to safeguard the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) from a proposed $400 million funding cut that had originated from President Donald Trump’s rescission package. However, advocates caution that the battle is far from over.
Read MoreBy Michael Gwarisa In a landmark move that could transform the global fight against HIV, the World Health Organization (WHO) today issued new guidelines endorsing the use of injectable lenacapavir (LEN) administered twice a year as an additional pre-exposure prophylaxis (PrEP) option. The announcement was made at the 13th International AIDS Society Conference (IAS 2025)
Read MoreBy Staff Reporter Gilead Sciences has come under fire after announcing a secretive deal to supply its long-acting injectable HIV prevention drug, lenacapavir (LEN-LA), to the Global Fund to Fight AIDS, Tuberculosis and Malaria. The agreement—shrouded in indefinite price secrecy—has been widely condemned by civil society organisations, health advocates, and global health experts who warn
Read More
By Staff Reporter The WCTC Declaration calls upon the governments of the world to accelerate the implementation of all measures under the WHO FCTC in order to end the tobacco epidemic. Among other actions, it urges countries to: “Recognise the tobacco industry as the biggest barrier to global progress in tobacco control. Reject engagements with
Read MoreCNN — A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo.
Read More
The International Diabetes Federation (IDF) has officially designated malnutrition-related diabetes as “type 5 diabetes”, marking a significant step in addressing a long-overlooked health condition. The decision was made on 8 April 2025 during the IDF’s World Diabetes Congress in Bangkok, Thailand. This recognition aims to raise awareness of a disease that disproportionately affects young people in
Read MoreBy Michael Gwarisa Billionaire Elon Musk, who also serves as an advisor to United States President Donald Trump, has hinted at intervening in the ongoing funding crisis affecting global HIV programs—particularly the rollout of Lenacapavir, a groundbreaking once-a-year HIV prevention drug. Musk made the remarks during a conversation with Bloomberg’s Mitchell Hussein at the Qatar
Read MoreFormer US president’s office said the cancer cells had spread to the bone and Biden, 82, was reviewing treatment options with doctors Former US President Joe Biden has been diagnosed with an “aggressive form” of prostate cancer that has metastasised to the bone, and he and his family are reviewing treatment options with doctors, his
Read More